Scores by kind of claim
Each kind of claim is scored on its own, out of 100: the share that held up, with the range it likely falls in. Fewer resolved claims give a wider range.
-
Factual claims
Statements about the present or the past, checked against the record: did they hold up?
77 71 83 -
Predictions
Statements about events outside the person's control, checked once they fell due: did they come true?
58 38 77
All types combined: 75 (likely 70 to 81, high confidence), from 85 claims: 79 factual claims, 6 predictions. It mixes kinds of claim in different proportions for different people, so compare people kind by kind.
Bill Gates's claims
34 claims
“For example, we were optimistic that vaginal gels could help prevent infection, but they weren’t effective at stopping transmission of the disease.”
Bill Gates, writing in annual letter section 10 February 2020 Why we swing for the fences (2020 Annual Letter) (Gates Notes)
Vaginal gels were not effective at stopping HIV transmission, despite the foundation's optimism that they could prevent infection.
Mostly true True in substance, wrong in a detail.
Said for an organisation they lead or work for; it counts on both records.
What would count as true or false
TRUE: major clinical trials of vaginal microbicide gels against HIV completed before February 2020 (for example VOICE, FACTS 001, and the confirmatory follow-ups to CAPRISA 004 with tenofovir gel) failed to show meaningful efficacy in preventing HIV transmission, and the Gates Foundation had funded or backed these gels. MOSTLY TRUE: the gels failed overall in the decisive trials, but one trial showed partial or adherence-dependent efficacy (for example CAPRISA 004's roughly 39% reduction) that the blanket statement skips over. MIXED: the trial evidence was genuinely split, with some gels showing efficacy that regulators or guidelines accepted. MOSTLY FALSE: a vaginal gel was shown effective and adopted, with failures limited to some products. FALSE: vaginal gels were demonstrated effective at stopping HIV transmission.
Evidence
- New tenofovir gel study shows no effect on HIV prevention: Lower than expected gel use impact FACTS trial results CAPRISA (Centre for the AIDS Programme of Research in South Africa) · 24 February 2015
“The FACTS 001 trial involving 2059 South African women showed no overall HIV prevention benefit of the gel. However, a sub-group analysis based on gel use confirmed by tenofovir detection in genital fluid, showed a 52% reduction in HIV infection.”
- New tenofovir gel study shows no effect on HIV prevention: Lower than expected gel use impact FACTS trial results CAPRISA (Centre for the AIDS Programme of Research in South Africa) · 24 February 2015
“The CAPRISA study had reported in 2010 that tenofovir, applied as a gel before and after sex, reduced HIV infection by 39% overall and by 54% in women who used the gel consistently.”
- New tenofovir gel study shows no effect on HIV prevention: Lower than expected gel use impact FACTS trial results CAPRISA (Centre for the AIDS Programme of Research in South Africa) · 24 February 2015
“The VOICE study recently reported no impact of tenofovir gel on HIV prevention because many of the women in that trial did not adhere to the daily dosing regimen.”
Reasoning
CAPRISA's 2015 release reports that the FACTS 001 trial of tenofovir gel showed no overall HIV prevention benefit (E1). It also says the VOICE trial found the gel had no effect, which it put down to poor adherence (E3). The same release notes that CAPRISA 004 had reported a 39% overall reduction in 2010, and E1 records a 52% reduction among women whose gel use was confirmed. The blanket statement leaves out these partial and adherence-dependent results (E2, E1). None of the evidence covers the Gates Foundation's funding or optimism, but the main claim that the gels failed in the decisive trials is supported.
Cite this claim
Bill Gates, “Vaginal gels were not effective at stopping HIV transmission, despite the foundation's optimism that they could prevent infection.” (said 10 February 2020). Verdict: mostly true. Reliability API, claim c_dc3aeaa1f9ad, method 0.1.0+c876030c. https://epistacklabs.com/claims/c_dc3aeaa1f9ad
Claims without a verdict
Is a verdict here wrong, or do you speak for Bill Gates? Reply on the claim's own page, with the form at its foot (how replies work). Verdicts are made automatically; how verdicts and scores are made.